Bipolar Disorder Trial, Recruiting NCT02604277 Sponsor: Emory University Condition: Bipolar Disorder
Back to Bipolar Disorder

Bipolar Disorder Trial, Recruiting

NCT02604277
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be able to speak and understand English
  • You have been diagnosed with Bipolar Disorder
  • You are able to read, understand, and sign a consent form agreeing to take part

Who may not be able to join:

  • You have significant problems with memory, thinking, or understanding (cognitive impairments)
  • You are currently experiencing a severe episode of psychosis (losing touch with reality)
  • You have a serious, unstable medical health condition at this time
  • You have a history of schizophrenia or a related condition
  • You have a history of psychotic symptoms that were not related to your mood episodes (confirm with trial site)
  • You have a history of a primary substance use disorder (such as serious problems with alcohol or drugs being the main diagnosis)
  • You have a history of a brain or neurological disease, or dementia

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Dorian Lamis, PhD, Emory University

Phone: (404) 616-3533

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 January 2016
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Columbia-Suicide Severity Rating Scale (C-SSRS) Score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov